BioLineRx (BLRX) Market Capitalization (2015 - 2026)
Powered by 
Analysis
BioLineRx (BLRX) Market Capitalization (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | BioLineRx | 6.68 Bn | 6.68 Bn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.15 Bn |
| Mar 31, 2026 | 6.00 Bn |
| Dec 31, 2025 | 7.23 Bn |
| Sep 30, 2025 | 4.53 Bn |
| Jun 30, 2025 | 5.48 Bn |
| Mar 31, 2025 | 3.55 Bn |
| Dec 31, 2024 | 10.06 Bn |
| Sep 30, 2024 | 23.47 Bn |
| Jun 30, 2024 | 24.77 Bn |
| Mar 31, 2024 | 48.68 Bn |
| Dec 31, 2023 | 68.24 Bn |
| Sep 30, 2023 | 67.19 Bn |
| Jun 30, 2023 | 59.07 Bn |
| Mar 31, 2023 | 32.86 Bn |
| Dec 31, 2022 | 21.78 Bn |
| Sep 30, 2022 | 26.60 Bn |
| Jun 30, 2022 | 36.62 Bn |
| Mar 31, 2022 | 48.92 Bn |
| Dec 31, 2021 | 58.36 Bn |
| Sep 30, 2021 | 27.81 Bn |